Brooks Laboratories Ltd
₹65.54
(6.54%)
Tue, 13 Oct 2026, 11:41 pm
Health Technology
Pharmaceuticals: Major
24.5KBrooks Laboratories News
Brooks Laboratories accepts resignation of company secretary
Brooks Laboratories Ltd has accepted the resignation of Ms. Krutika Rane as Company Secretary and Compliance Officer, effective October 9, 2026. She leaves to pursue an alternate career opportunity outside the organization.
16 Sept 2026
companies
Brooks Labs appoints Rajesh Mahajan as President
Brooks Laboratories Ltd appointed Mr. Rajesh Mahajan as President - Trading effective July 17, 2026. He brings over 20 years of pharma industry experience.
17 Jul 2026
companies
Brooks Labs sets up wholly owned subsidiary
Brooks Laboratories incorporated Abridge Speciality Limited on July 2, 2026. The new entity will focus on pharmaceutical manufacturing and marketing.
02 Jul 2026
companies
Brooks Labs sells shares for ₹106.33 crore
Brooks Laboratories Ltd approved the sale of shares in Brooks Steriscience for ₹106.33 crore to Steriscience Specialties.
19 Jun 2026
companies
Brooks Labs appoints Prashant Rathi as CEO
Brooks Laboratories appointed Mr. Prashant Rathi as CEO effective June 1, 2026. He retains his role as CFO.
30 May 2026
companies
Market Current News
RBI introduces forex reserve requirement
RBI Governor introduces forex reserve requirement to curb excessive buying speculation. Clarifies measures are not capital controls and anticipates $150 billion inflows.
13 Oct 2026
currency
Fusion CX IPO: ₹1,818 Cr Revenue; AI-Driven CX Leader
Fusion CX Ltd, a global CX and BPO provider, reports ₹1,818.14 Cr FY2026 revenue. IPO proceeds target debt repayment and AI upgrades.
13 Oct 2026
ipo
Vaibhav Vyapaar IPO Day 1: 0.04x
Vaibhav Vyapaar IPO saw sluggish demand on Day 1 with total subscription at 0.04x. Retail led at 0.07x, while QIB interest remained negligible.
13 Oct 2026
ipo
HD Fire Protect IPO Day 1: NII leads at 2.26x
HD Fire Protect IPO opens on Day 1 with overall subscription at 0.81x. NII (sHNI) leads at 2.26x, while QIB participation is yet to begin. Retail at 0.87x.
13 Oct 2026
ipo
Tonbo Imaging IPO: Pure OFS, No Fresh Issue
Tonbo Imaging files DRHP for a pure Offer for Sale. Revenue fell to ₹3,626 cr in FY26. No proceeds go to the company; all funds go to selling shareholders.
13 Oct 2026
ipo
